ARLZ
Aralez Pharmaceuticals Inc.
ARLZ
ARLZ
Delisted
ARLZ was delisted on the 20th of August, 2018.
48 hedge funds and large institutions have $1.8M invested in Aralez Pharmaceuticals Inc. in 2018 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
-8
Holders Change %
-14.29%
% of All Funds
1.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
13
Reduced
12
Closed
12
Calls
$66K
Puts
$67K
Net Calls
-$1K
Net Calls Change
+$6K
Top Buyers
| 1 |
SM
Salzhauer Michael
|
+$97.1K |
| 2 |
SCP
Silverleafe Capital Partners
Germantown,
Tennessee
|
+$35K |
| 3 |
Renaissance Technologies
New York
|
+$32.6K |
| 4 |
Millennium Management
New York
|
+$19K |
| 5 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
+$18.2K |
